Mechanism and prevention of ischemia-reperfusion injury of donor lung transplantation

doi:10.3877/cma.j.issn.2095-8773.2023.04.10

Abstract

Abstract:

Ischemia reperfusion injury (IRI) is one of the main causes of lung transplantation failure. In this review, we summarized the current status of IRI after lung transplantation in recent years, pathophysiological mechanisms, the current effective therapeutic measures, and the future progress of this clinical problem.

Key words: Lung transplantation, Donor lung, Ischemia reperfusion injury, Mechanism, Prevention

Ning Li, Yan Liu, Huiqing Lin. Mechanism and prevention of ischemia-reperfusion injury of donor lung transplantation[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2023, 10(04): 247-256.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxbwkdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-8773.2023.04.10

https://zhxbwkdzzz.cma-cmc.com.cn/EN/Y2023/V10/I04/247

References 81

1	陈实．肺移植发展历程[J]．中华器官移植杂志，2022，43（8）：451-455．
2	刘峰，陈静瑜，叶书高，等．民用航空超长距离转运供肺肺移植（附6例报告）[J]．器官移植，2015（6）：374-377．
3	Laubach VE，Sharma AK．Mechanisms of lung ischemia-reperfusion injury[J]．Curr Opin Organ Transplant，2016，21（3）：246-252．
4	Kapnadak SG，Raghu G．Lung transplantation for interstitial lung disease[J]．Eur Respir Rev，2021，30（161）：210017．
5	Sadaf D，Ahmad MZ．Calcium hydroxide (CaOH(2)) as an intracanal medication may significantly reduce endotoxins level from infected teeth[J]．J Evid Based Dent Pract，2021，21（3）：101616．
6	Chambers DC，Cherikh WS，Harhay MO，et al．The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart-lung transplantation Report-2019; Focus theme: Donor and recipient size match[J]．J Heart Lung Transplant，2019，38（10）：1042-1055．
7	Swaminathan AC，Todd JL，Palmer SM．Advances in Human Lung Transplantation[J]．Annu Rev Med，2021，72：135-149．
8	Roesel MJ，Sharma NS，Schroeter A，et al．Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury[J]．Front Immunol，2022，13：891564．
9	Li S，Hafeez A，Noorulla F，et al．Preconditioning in neuroprotection: From hypoxia to ischemia[J]．Prog Neurobiol，2017，157：79-91．
10	Cui C，Zhou T，Li J，et al．Proteomic analysis of the mouse brain after repetitive exposure to hypoxia[J]．Chem Biol Interact，2015，236：57-66．
11	Fuhrmann DC，Brüne B．Mitochondrial composition and function under the control of hypoxia[J]．Redox Biol，2017，12：208-215．
12	Pak O，Sydykov A，Kosanovic D，et al．Lung Ischaemia-Reperfusion Injury: The Role of Reactive Oxygen Species[J]．Adv Exp Med Biol，2017，967：195-225．
13	Shi Q，Feng N，Ma Q，et al．ZNF354C Mediated by DNMT1 Ameliorates Lung Ischemia-Reperfusion Oxidative Stress Injury by Reducing TFPI Promoter Methylation to Upregulate TFPI[J]．Oxid Med Cell Longev，2022，2022：7288729．
14	Chatterjee S，Nieman GF，Christie JD，et al．Shear stress-related mechanosignaling with lung ischemia: lessons from basic research can inform lung transplantation[J]．Am J Physiol Lung Cell Mol Physiol，2014，307（9）：L668-L680．
15	Ottolia M，John S，Hazan A，et al．The Cardiac Na(+) -Ca(2+) Exchanger: From Structure to Function[J]．Compr Physiol，2021，12（1）：2681-2717．
16	Hernansanz-Agustín P，Choya-Foces C，Carregal-Romero S，et al．Na(+) controls hypoxic signalling by the mitochondrial respiratory chain[J]．Nature，2020，586（7828）：287-291．
17	Zhang W，Qi Z，Wang Y．BTP2, a Store-Operated Calcium Channel Inhibitor, Attenuates Lung Ischemia-Reperfusion Injury in Rats[J]．Inflammation，2017，40（3）：778-787．
18	Mohamed MS．Calcium-activated potassium channels in ischemia-reperfusion: learning for the clinical application[J]．Front Med (Lausanne)，2015，2：21．
19	Singh S，Mabalirajan U．Mitochondrial calcium in command of juggling myriads of cellular functions[J]．Mitochondrion，2021，57：108-118．
20	Bovo E，Mazurek SR，Zima AV．Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca(2+) waves during β-adrenergic receptor stimulation[J]．Am J Physiol Heart Circ Physiol，2018，315（4）：H1032-H1040．
21	Tan Y，Mui D，Toan S，et al．SERCA Overexpression Improves Mitochondrial Quality Control and Attenuates Cardiac Microvascular Ischemia-Reperfusion Injury[J]．Mol Ther Nucleic Acids，2020，22：696-707．
22	Peng CK，Huang KL，Wu CP，et al．Glutamine protects ischemia-reperfusion induced acute lung injury in isolated rat lungs[J]．Pulm Pharmacol Ther，2011，24（1）：153-161．
23	Li W，Terada Y，Tyurina YY，et al．Necroptosis triggers spatially restricted neutrophil-mediated vascular damage during lung ischemia reperfusion injury[J]．Proc Natl Acad Sci U S A，2022，119（10）：e2111537119．
24	Hashemi P，Nouri-Vaskeh M，Alizadeh L，et al．NETosis in ischemic/reperfusion injuries: An organ-based review[J]．Life Sci，2022，290：120158．
25	Wang JF，Wang YP，Xie J，et al．Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis[J]．Blood，2021，138（9）：806-810．
26	Livingston MJ，Wang J，Zhou J，et al．Clearance of damaged mitochondria via mitophagy is important to the protective effect of ischemic preconditioning in kidneys[J]．Autophagy，2019，15（12）：2142-2162．
27	Tang B，Luo Z，Zhang R，et al．An update on the molecular mechanism and pharmacological interventions for Ischemia-reperfusion injury by regulating AMPK/mTOR signaling pathway in autophagy[J]．Cell Signal，2023，107：110665．
28	Zhan Y，Ling Y，Deng Q，et al．HMGB1-Mediated Neutrophil Extracellular Trap Formation Exacerbates Intestinal Ischemia/Reperfusion-Induced Acute Lung Injury[J]．J Immunol，2022，208（4）：968-978．
29	Sayah DM，Mallavia B，Liu F，et al．Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation[J]．Am J Respir Crit Care Med，2015，191（4）：455-463．
30	Bonneau S，Landry C，Bégin S，et al．Correlation between Neutrophil Extracellular Traps (NETs) Expression and Primary Graft Dysfunction Following Human Lung Transplantation[J]．Cells，2022，11（21）：3420．
31	Mallavia B，Liu F，Lefrançais E，et al．Mitochondrial DNA Stimulates TLR9-Dependent Neutrophil Extracellular Trap Formation in Primary Graft Dysfunction[J]．Am J Respir Cell Mol Biol，2020，62（3）：364-372．
32	Calabrese DR，Tsao T，Magnen M，et al．NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes[J]．JCI Insight，2022，7（24）：e164603．
33	Wong A，Liu M．Inflammatory responses in lungs from donation after brain death: Mechanisms and potential therapeutic targets[J]．J Heart Lung Transplant，2021，40（9）：890-896．
34	Wong A，Zamel R，Yeung J，et al．Potential therapeutic targets for lung repair during human ex vivo lung perfusion[J]．Eur Respir J，2020，55：1902222．
35	Baciu C，Sage A，Zamel R，et al．Transcriptomic investigation reveals donor-specific gene signatures in human lung transplants[J]．Eur Respir J，2021，57：2000327．
36	Capuzzimati M，Hough O，Liu M．Cell death and ischemia-reperfusion injury in lung transplantation[J]．J Heart Lung Transplant，2022，41（8）：1003-1013．
37	Kanou T，Ohsumi A，Kim H，et al．Inhibition of regulated necrosis attenuates receptor-interacting protein kinase 1-mediated ischemia-reperfusion injury after lung transplantation[J]．J Heart Lung Transplant，2018，37（10）：1261-1270．
38	Wang Y，Dong Z，Zhang Z，et al．Postconditioning with Irisin Attenuates Lung Ischemia/Reperfusion Injury by Suppressing Ferroptosis via Induction of the Nrf2/HO-1 Signal Axis[J]．Oxid Med Cell Longev，2022，2022：9911167．
39	Liu WC，Chen SB，Liu S，et al．Inhibition of mitochondrial autophagy protects donor lungs for lung transplantation against ischaemia-reperfusion injury in rats via the mTOR pathway[J]．J Cell Mol Med，2019，23（5）：3190-3201．
40	Park E，Chung SW．ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation[J]．Cell Death Dis，2019，10（11）：822．
41	毛文君，陈静瑜，郑明峰，等．公民逝世后器官捐献供肺移植242例的临床疗效分析[J]．中华器官移植杂志，2017，38（11）：676-681．
42	Sef D，Verzelloni Sef A，Mohite P，et al．Utilization of extracorporeal membrane oxygenation in DCD and DBD lung transplants: a 2-year single-center experience[J]．Transpl Int，2020，33（12）：1788-1798．
43	Porteous MK，Diamond JM，Christie JD．Primary graft dysfunction: lessons learned about the first 72 h after lung transplantation[J]．Curr Opin Organ Transplant，2015，20（5）：506-514．
44	Haverich A，Aziz S，Scott WC，et al．Improved lung preservation using Euro-Collins solution for flush-perfusion[J]．Thorac Cardiovasc Surg，1986，34（6）：368-376．
45	Hausen B，Beuke M，Schroeder F，et al．In vivo measurement of lung preservation solution efficacy: comparison of LPD, UW, EC and low K+-EC following short and extended ischemia[J]．Eur J Cardiothorac Surg，1997，12（5）：771-779；discussion 779-780．
46	Ikeda M，Bando T，Yamada T，et al．Clinical application of ET-Kyoto solution for lung transplantation[J]．Surg Today，2015，45（4）：439-443．
47	Van De Wauwer C，Neyrinck AP，Rega FR，et al．Retrograde flush is more protective than heparin in the uncontrolled donation after circulatory death lung donor[J]．J Surg Res，2014，187（1）：316-323．
48	Saren G，Wong A，Lu YB，et al．Ischemia-Reperfusion Injury in a Simulated Lung Transplant Setting Differentially Regulates Transcriptomic Profiles between Human Lung Endothelial and Epithelial Cells[J]．Cells，2021，10（10）：2713．
49	Beer A，Reed RM，Bölükbas S，et al．Mechanical ventilation after lung transplantation. An international survey of practices and preferences[J]．Ann Am Thorac Soc，2014，11（4）：546-553．
50	Hoetzenecker K，Benazzo A，Stork T，et al．Bilateral lung transplantation on intraoperative extracorporeal membrane oxygenator: An observational study[J]．J Thorac Cardiovasc Surg，2020，160（1）：320-327.e1．
51	Nathan SD．The future of lung transplantation[J]．Chest，2015，147（2）：309-316．
52	Steen S，Sjöberg T，Pierre L，et al．Transplantation of lungs from a non-heart-beating donor[J]．Lancet，2001，357（9259）：825-829．
53	Warnecke G，Moradiellos J，Tudorache I，et al．Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients[J]．Lancet，2012，380（9856）：1851-1858．
54	Cypel M，Yeung JC，Donahoe L，et al．Normothermic ex vivo lung perfusion: Does the indication impact organ utilization and patient outcomes after transplantation?[J]．J Thorac Cardiovasc Surg，2020，159（1）：346-355.e1．
55	Tian D，Wang Y，Shiiya H，et al．Outcomes of marginal donors for lung transplantation after ex vivo lung perfusion: A systematic review and meta-analysis[J]．J Thorac Cardiovasc Surg，2020，159（2）：720-730.e6．
56	Luo Q，Zhu L，Wang Y，et al．The Conversional Efficacy of Ex Vivo Lung Perfusion and Clinical Outcomes in Patients Undergoing Transplantation of Donor Lungs by Ex Vivo Lung Perfusion: A Meta-Analysis[J]．Ann Transplant，2019，24：647-660．
57	Wang A，Ali A，Keshavjee S，et al．Ex vivo lung perfusion for donor lung assessment and repair: a review of translational interspecies models[J]．Am J Physiol Lung Cell Mol Physiol，2020，319（6）：L932-L940．
58	Cypel M，Yeung JC，Hirayama S，et al．Technique for prolonged normothermic ex vivo lung perfusion[J]．J Heart Lung Transplant，2008，27（12）：1319-1325．
59	Lonati C，Bassani GA，Brambilla D，et al．Influence of ex vivo perfusion on the biomolecular profile of rat lungs[J]．FASEB J，2018，32（10）：5532-5549．
60	Chen F，Nakamura T，Fujinaga T，et al．Protective effect of a nebulized beta2-adrenoreceptor agonist in warm ischemic-reperfused rat lungs[J]．Ann Thorac Surg，2006，82（2）：465-471．
61	Yamada T，Chen F，Sakamoto J，et al．Impact of the cardiac arrest mode on cardiac death donor lungs[J]．J Surg Res，2015，195（2）：596-603．
62	Kermeen FD，McNeil KD，Fraser JF，et al．Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant[J]．J Heart Lung Transplant，2007，26（8）：850-856．
63	Ohsumi A，Chen F，Sakamoto J，et al．Protective effect of pre-recovery surfactant inhalation on lungs donated after cardiac death in a canine lung transplantation model[J]．J Heart Lung Transplant，2012，31（10）：1136-1142．
64	Valenza F，Rosso L，Coppola S，et al．β-adrenergic agonist infusion during extracorporeal lung perfusion: effects on glucose concentration in the perfusion fluid and on lung function[J]．J Heart Lung Transplant，2012，31（5）：524-530．
65	Sakamoto J，Chen F，Nakajima D，et al．The effect of β-2 adrenoreceptor agonist inhalation on lungs donated after cardiac death in a canine lung transplantation model[J]．J Heart Lung Transplant，2012，31（7）：773-779．
66	Wu JX，Zhu HW，Chen X，et al．Inducible nitric oxide synthase inhibition reverses pulmonary arterial dysfunction in lung transplantation[J]．Inflamm Res，2014，63（8）：609-618．
67	Meade MO，Granton JT，Matte-Martyn A，et al．A randomized trial of inhaled nitric oxide to prevent ischemia-reperfusion injury after lung transplantation[J]．Am J Respir Crit Care Med，2003，167（11）：1483-1489．
68	Ryter SW，Choi AM．Carbon monoxide: present and future indications for a medical gas[J]．Korean J Intern Med，2013，28（2）：123-140．
69	Akhtar MZ，Sutherland AI，Huang H，et al．The role of hypoxia-inducible factors in organ donation and transplantation: the current perspective and future opportunities[J]．Am J Transplant，2014，14（7）：1481-1487．
70	Ohsawa I，Ishikawa M，Takahashi K，et al．Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals[J]．Nat Med，2007，13（6）：688-694．
71	Haam S，Lee S，Paik HC，et al．The effects of hydrogen gas inhalation during ex vivo lung perfusion on donor lungs obtained after cardiac death[J]．Eur J Cardiothorac Surg，2015，48（4）：542-547．
72	Liu H，Liang X，Wang D，et al．Combination therapy with nitric oxide and molecular hydrogen in a murine model of acute lung injury[J]．Shock，2015，43（5）：504-511．
73	Takahashi M，Chen-Yoshikawa TF，Saito M，et al．Immersing lungs in hydrogen-rich saline attenuates lung ischaemia-reperfusion injury[J]．Eur J Cardiothorac Surg，2017，51（3）：442-448．
74	Chen-Yoshikawa TF．Ischemia-Reperfusion Injury in Lung Transplantation[J]．Cells，2021，10（6）：1333．
75	Motoyama H，Chen F，Ohsumi A，et al．Protective effect of plasmin in marginal donor lungs in an ex vivo lung perfusion model[J]．J Heart Lung Transplant，2013，32（5）：505-510．
76	Tian W，Liu Y，Zhang B，et al．Infusion of mesenchymal stem cells protects lung transplants from cold ischemia-reperfusion injury in mice[J]．Lung，2015，193（1）：85-95．
77	Stone ML，Zhao Y，Robert Smith J，et al．Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death[J]．Respir Res，2017，18（1）：212．
78	Antunes MA，Laffey JG，Pelosi P，et al．Mesenchymal stem cell trials for pulmonary diseases[J]．J Cell Biochem，2014，115（6）：1023-1032．
79	Nakajima D，Watanabe Y，Ohsumi A，et al．Mesenchymal stromal cell therapy during ex vivo lung perfusion ameliorates ischemia-reperfusion injury in lung transplantation[J]．J Heart Lung Transplant，2019，38（11）：1214-1223．
80	Matthay MA，Calfee CS，Zhuo H，et al．Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial[J]．Lancet Respir Med，2019，7（2）：154-162．
81	Chambers DC，Enever D，Lawrence S，et al．Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study[J]．Stem Cells Transl Med，2017，6（4）：1152-1157．

[1]	Bohui Shi, Xiping Ding, Lian Wang, Rong Li, Pingli Guo, Jing Qi, Yao Chen, Na Hao, Yu Ren. Summary of best evidences for prevention and treatment of subcutaneous seroma after breast cancer surgery [J]. Chinese Journal of Breast Disease(Electronic Edition), 2023, 17(05): 277-284.
[2]	Xiaoyan Zhang, Dongqiong Xiao, Hu Gao, Lin Chen, Fajuan Tang, Xihong Li. The protective effect and mechanism of overexpression of transcription factor 12 on the cerebral cortex of rats with sepsis-associated encephalopathy [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 540-549.
[3]	Meiqi Lu, Jie Zhao, Fei Shan, Xinglei Wang, Duyin Jiang. Research progress of drug-induced pyoderma gangrenosum [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(05): 447-450.
[4]	Xiaoyin Zhang, Yang Yu. Research progress on the occurrence and development of chronic kidney disease by Porphyromonas gingivalis [J]. Chinese Journal of Stomatological Research(Electronic Edition), 2023, 17(05): 328-334.
[5]	Yonghao Li, Xuefei Gao, Tiantian Guo, Jin Zhang, Caizhen Zhang, Jing Liu. Advances in the research of mechanisms related to obesity combined with thyroid carcinoma [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(04): 311-315.
[6]	Fei Chen, Yi Han, Yuwen Luo, Xiaolin Yi, Qiang Li. Influencing factors and prevention strategies of hypoparathyroidism after endoscopic thyroidectomy [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(03): 217-221.
[7]	Yingjun Tang, Huajuan Li, Saini Wang, Wang Xu, Feng Liu, Xi Li, Xinbao Hao, Huaping Huang. Effect and mechanism of human umbilical cord mesenchymal stem cells (HU-MSCs) transplantation on emphysema mice [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2023, 16(04): 476-480.
[8]	Junyong Ma, Yizhou Wang, Xifeng Li. Brief discussion on prevention and control strategy for bleeding in laparoscopic hepatectomy [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 495-498.
[9]	Jiafa Ren, Buyun Wu, Changying Xing, Huijuan Mao. Advances in the basic and clinical research on acute kidney injury in 2022 [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(05): 276-281.
[10]	Kunqi Zhang, Rui Zhang, Jia Xu, Qinglin Kang. The progress of the management of floating knee injury [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(04): 252-256.
[11]	Tian Li, Hong Xu, Heliang Liu. Progress in research of pneumoconiosis [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(08): 900-905.
[12]	Qiuyue Shen, Xinlin Hou. Advances in understanding of brain protective mechanisms of n-3 polyunsaturated fatty acids [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 471-478.
[13]	Xuping Zhang, Jiacheng Liu, Ge Zhang, Yanjiao Du, Shao Li, Dandan Shang, Hao Wang, Yan Li, Zhihui Duan. CYP2C19 gene polymorphism combined with thromboelastogram-guided antiplatelet therapy for patients with the large artery atherosclerosis and non-disabling ischemic cerebrovascular events (NICE) [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(05): 477-481.
[14]	Chenjun Yin, Zhe Zhang, Xiaoming Li. Advance in mechanisms of patent foramen ovale-associated thrombosis [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(04): 307-311.
[15]	Ling Yu, Zhiyu Zhang, Zhe Zhang, Yu Fu. Progress of common triggers of migraine and its applications in disease management [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(04): 400-403.

Please choose a citation manager

Content to export